The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group

The effect of addition of selenium to treatment regimen of hospitalized patients with COVID-19 on the outcome of disease compared with control group

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160706028815N5

Enrollment

Registered

2020-05-05

Start date

2020-05-20

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 treatment. Coronavirus disease (covid-19)

Interventions

Intervention 1: Intervention group: Intervention group until discharge, in addition to antiviral treatments according to the national protocol, injectable selenium will be prescribed in the form of 10

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: COVID-19 patient Presence of COVID-19 infection in the lung imaging COVID-19 PCR positive patients Age more than 18 years old

Exclusion criteria

Exclusion criteria: Mechanical ventilation

Design outcomes

Primary

Measure	Time frame
Need mechanical ventilation. Timepoint: during hospitalization. Method of measurement: daily visit.;Need to be hospitalized in the intensive care unit. Timepoint: during hospitalization. Method of measurement: daily visit.;Duration of hospitalization. Timepoint: during hospitalization. Method of measurement: daily visit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsaneh Kaffash

Sabzevar University of Medical Sciences

DrKaffash@yahoo.com+98 51 4401 4000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026